United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - mercaptamine hydrochloride - eye drops - 5.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - mercaptamine hydrochloride - eye drops - 1.1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - mercaptamine hydrochloride - eye drops - 5.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - mercaptamine hydrochloride - eye drops - 5mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - mercaptamine (cysteamine) bitartrate, quantity: 441.72 mg (equivalent: mercaptamine (cysteamine), qty 150 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; sodium lauryl sulfate; silicon dioxide; croscarmellose sodium; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the management of nephropathic cystinosis in children and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - mercaptamine (cysteamine) bitartrate, quantity: 147.24 mg (equivalent: mercaptamine (cysteamine), qty 50 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; sodium lauryl sulfate; silicon dioxide; croscarmellose sodium; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the management of nephropathic cystinosis in children and adults.

European Union - English - EMA (European Medicines Agency)

recordati rare diseases - mercaptamine hydrochloride - cystinosis - ophthalmologicals - cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (germany) - mercaptamine hydrochloride - powder - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

orphan europe (uk - mercaptamine hydrochloride - eye drops - 3.8mg/1ml

Israel - English - Ministry of Health

medison pharma ltd - mercaptamine as hydrochloride - ophthalmic solution - mercaptamine as hydrochloride 3.8 mg - mercaptamine - cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.